pocketful logo light
pocketful logo light
Indoco Remedies Ltd logo

Indoco Remedies Ltd

NSE: INDOCO BSE: 532612

₹257.59

(3.45%)

Tue, 22 Sept 2026, 07:56 pm

mtf coin illustrationMTF 5x

Indoco Remedies Share Price Live Chart

1 Day

(3.45%)

No Result Found

Summary

  • Market Cap (in Cr)

    1935.15

  • Net Profit (in Cr)

    -77.95

  • P/B

    2.11

  • Sector P/E

    33.76

  • P/E

    0

  • EV/EBITDA

    29.60

  • Debt/Equity (Industry)

    0.24

  • Interest Cover (Industry)

    9.79

  • ROCE (Industry)

    14.04

  • RONW (Industry)

    13.17

  • ROE

    -7.31

  • ROCE

    -0.42

  • Debt/Equity

    0.78

  • EPS (TTM)

    0

  • Dividend Yield

    0.10

  • Book Value

    101.76

  • Interest Cover

    -0.12

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters58.8658.9058.9058.9058.90
FII0.941.101.251.221.24
DII18.1518.1518.1618.9618.75
Public22.0421.8521.6920.9221.11
Government00000

Read More

Technical Analysis

RSI

54.15

MACD

5.45

50 DMA

237.60

200 DMA

222.37

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic316.31276.67260.01237.03220.37197.39157.75
Fibonacci276.67261.53252.18237.03221.89212.54197.39
Camarilla254.24250.61246.97237.03239.71236.07232.44

Pivots Level: Classic

R3

+79.28

316.31

R2

+39.64

276.67

R1

+22.97

260.01

237.03
237.03
Pivot Point
LTP: 254.51

S1

-16.67

220.37

S2

-39.64

197.39

S3

-79.28

157.75

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    252.17

  • 20-EMA

    248.13

  • 30-EMA

    244.76

  • 50-EMA

    240.16

  • 100-EMA

    233.91

  • 200-EMA

    235.20

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
07 May 2026board-meetingsAccounts, Final Dividend
03 Feb 2026board-meetingsQuarterly Results
06 Nov 2025board-meetingsQuarterly Results, Half Yearly Results
14 Aug 2025agm
04 Aug 2025dividendFinal Dividend - Rs. - 0.204 Sept 2025
22 May 2025dividend₹0.20 Dividend /Share04 Sept 2025
30 Aug 2024agm
19 Aug 2024dividendAnnual General Meeting/Dividend - Rs 1.50 Per Share20 Sept 2024
16 May 2024dividend₹1.50 Dividend /Share19 Sept 2024
28 Aug 2023agm

Read More

Peer Comparison

Indoco Remedies Ltd logo

Indoco Remedies Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Cipla Ltd logo

Cipla Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Read More

Indoco Remedies Ltd About

Indoco Remedies is engaged in the manufacturing and marketing of Formulations and Active Pharmaceutical Ingredients. The Company caters to both Domestic and International markets.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1947

Headquarters

CEO

Suresh G Kare

Employees

Contact

Website icon

Website

http://www.indoco.com

Email icon

Email

compliance.officer@indoco.com

Phone icon

Phone

91-022-26541851-55

Location icon

Location

Indoco House 166 C S T Road, Santacruz (East) Kalina, Mumbai, Maharashtra, 400098

Read More

Indoco Remedies Ltd Company History

YearHistory
2020
  • Indoco wins major tenders in Germany for Allopurinol Tablets
  • Indoco receives USFDA approval for Apixaban Tablets 2.5 mg & 5 mg
  • Indoco awarded with the IDMA Formulations Best Patent Award 2018-19 for 2 formulation patents Diclofenac & Quetiapine
  • Indoco receives USFDA approval for Succinylcholine Chloride Injection USP
  • Indoco receives USFDA approval for Olanzapine Tablets
2021
  • Indoco announces the launch of Brinzolamide Ophthalmic Suspension 1% in the US market by Teva Pharmaceuticals
2022
  • Indoco Remedies to acquire stake in Kanakal Wind Energy.
  • Indoco Remedies receives USFDA approval for Lacosamide Injection USP.
  • Indoco Remedies receives USFDA approval for Lacosamide Tablets.
2023
  • Indoco Remedies receives tentative ANDA approval from USFDA for Canagliflozin Tablets.
  • Indoco acquires 85 % equity stake in US based FPP Holding Company, LLC.
  • Indoco receives EIR for its manufacturing facility in Goa (Plant I).
2024
  • Indoco enters into a strategic distribution partnership with Clarity Pharma, UK.
  • Indoco Remedies receives final ANDA approval from USFDA for Varenicline Tablets, 0.5 mg and 1 mg
  • Indoco Remedies receives final ANDA approval from USFDA for Pregabalin capsules.
  • Indoco Remedies receives tentative ANDA approval from USFDA for Canagliflozin and Metformin Hydrochloride Tablets.
  • USFDA successfully completes inspection at Indoco's API Kilo Lab manufacturing facility and IAS division without any observations.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
ICICI PRUDENTIAL MUTUAL FUNDbulkBuy68354419827 May 2026
ICICI PRUDENTIAL MUTUAL FUNDbulkBuy67445819827 May 2026
XTX MARKETS LLPbulkBuy478901507.9412 Aug 2021
XTX MARKETS LLPbulkSell481713508.5112 Aug 2021
DOVETAIL INDIA FUND CLASS 6 SHARESbulkBuy500000265.3102 Dec 2020
OHM JUNIPER LONGTERM FUND LTDbulkSell500000265.3102 Dec 2020
DSP AIF PHARMA FUNDbulkSell127643414010 Oct 2019
DSP AIF PHARMA FUNDblockSell127643414010 Oct 2019
DSP MUTUAL FUNDbulkBuy127643414010 Oct 2019
DSP MUTUAL FUNDblockBuy127643414010 Oct 2019

Read More

Indoco Remedies Ltd News

Indoco Remedies approves new subsidiary

Indoco Remedies Limited has approved the incorporation of Warren Lifesciences Private Limited as a wholly owned subsidiary. The entity will operate in the pharmaceutical sector with an initial paid-up capital of ₹1 lakh.

18 Sept 2026

companies

Indoco Remedies holds 79th AGM, voting results out

Indoco Remedies disclosed voting results of its 79th Annual General Meeting held on September 17, 2026, via video conferencing, along with the scrutinizer's consolidated report.

18 Sept 2026

companies

Indoco Remedies AGM: Dividend, Borrowing Limits Approved

Indoco Remedies shareholders approved a ₹0.20 final dividend for FY26 and increased borrowing limits at the 79th AGM held on September 17, 2026.

17 Sept 2026

companies

Indoco Remedies clears UK MHRA CGMP inspection

Indoco Remedies' Goa facility successfully completed a UK MHRA CGMP inspection with no critical or major observations, signalling strong regulatory compliance.

10 Sept 2026

companies

Indoco Remedies promoters buy 38,930 shares

Promoters of Indoco Remedies acquired 38,930 equity shares in the open market on September 8 and 9, 2026. The group's stake rose to 7.30% with no encumbrances reported.

10 Sept 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Indoco Remedies Ltd?

    As of 23/09/2026 at 1:26 AM, Indoco Remedies Ltd shares are trading at ₹257.59.

  • 2.What is the market cap. of Indoco Remedies Ltd?

    As of 23/09/2026, the market capitalization of Indoco Remedies Ltd is ₹2,301.59 crore.

  • 3.When was Indoco Remedies Ltd founded?

    Indoco Remedies Ltd was founded in 1947.

  • 4.What are the P/E and P/B ratios of Indoco Remedies Ltd?

    As of 23/09/2026, Indoco Remedies Ltd has a P/E ratio of 421.45 and a P/B ratio of 2.11.

  • 5.How can I buy shares of Indoco Remedies Ltd?

    You can buy shares of Indoco Remedies Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.What is the shareholding pattern of Indoco Remedies Ltd?

    As of March,2026, promoters hold 58.86% in Indoco Remedies Ltd, while FIIs, DIIs and public shareholders hold 0.94%, 18.15% and 22.04%, respectively.

  • 7.Does Indoco Remedies Ltd pay dividends?

    Yes, Indoco Remedies Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹Final Dividend - Rs. - 0.2 per share.

  • 8.What is the dividend yield of Indoco Remedies Ltd?

    As of 23 September, 2026, the dividend yield of Indoco Remedies Ltd stands at 0.08%.

  • 9.What are the latest financial results of Indoco Remedies Ltd?

    For January,2024, Indoco Remedies Ltd reported revenue of ₹1,643.00 crore and a net profit of ₹-73.74 crore.

  • 10.What is the Stock symbol of Indoco Remedies Ltd?

    INDOCO is the stock symbol of Indoco Remedies Ltd.

  • 11.Who is the CEO of Indoco Remedies Ltd?

    The CEO of Indoco Remedies Ltd is Suresh G Kare.

Open Your Free Demat Account

Enter your phone number